Experiences with benzodiazepine use, tapering, and discontinuation: an Internet survey

Experiences with benzodiazepine use, tapering, and discontinuation: an Internet survey

The benzodiazepine experience survey was designed by Dr. Jane Macoubrie, a professor of communications and member of BIC’s general advisory board, and Dr. Christy Huff, director of Benzodiazepine Information Coalition, who both have lived experience…

Benzodiazepine-focused webinar series, sponsored by the Consortium’s Benzodiazepine Action Work Group

Benzodiazepine-focused webinar series, sponsored by the Consortium’s Benzodiazepine Action Work Group

Please join the Colorado Consortium’s Benzodiazepine Action Work Group for our free CME lunch and learn webinar series. Webinar topics include alternative treatments to BZDs, consequences of BZD prescribed use, BZD Induced Neurologic Dysfunction (BIND),…

Psychiatric Drug Withdrawal Town Hall 3 – Post-Withdrawal Experiences

Psychiatric Drug Withdrawal Town Hall 3 – Post-Withdrawal Experiences

Mad in America, the Council for Evidence-based Psychiatry, International Institute for Psychiatric Drug Withdrawal and A Disorder 4 Everyone presented a series of live, online town hall discussions focussing on issues related to psychiatric drug…

Benzodiazepine-Induced Brain Injury: The Hidden Prescription Epidemic

Benzodiazepine-Induced Brain Injury: The Hidden Prescription Epidemic

Colorado Consortium’s 2021 Annual Meeting held a special session entitled Benzodiazepine-Induced Brain Injury: The Hidden Prescription Epidemic.  Download slides here The session featured presenters: Nicole Lamberson, PA, of Benzodiazepine Information Coalition’s Medical Advisory Board John Staight,…

Public Workshop: Safe Use of Benzodiazepines: Clinical, Regulatory, and Public Health Perspectives

Public Workshop: Safe Use of Benzodiazepines: Clinical, Regulatory, and Public Health Perspectives

Duke University’s Margolis Center for Health Policy, in cooperation with the FDA, held a public workshop Safe Use of Benzodiazepines: Clinical, Regulatory, and Public Health Perspectives on July 12 and 13. Our director, Dr. Christy Huff,…